Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Reduced bioavailability of tamoxifen and its metabolite 4-hydroxytamoxifen after oral administration with biochanin A (an isoflavone) in rats.

Singh SP, Wahajuddin, Raju KS, Ali MM, Kohli K, Jain GK.

Phytother Res. 2012 Feb;26(2):303-7. doi: 10.1002/ptr.3652. Epub 2011 Dec 1.

PMID:
22131128
2.

Liquid chromatography-mass spectrometry method for the quantification of tamoxifen and its metabolite 4-hydroxytamoxifen in rat plasma: application to interaction study with biochanin A (an isoflavone).

Singh SP, Wahajuddin, Ali MM, Kohli K, Jain GK.

J Chromatogr B Analyt Technol Biomed Life Sci. 2011 Oct 1;879(27):2845-51. doi: 10.1016/j.jchromb.2011.07.036. Epub 2011 Aug 2.

PMID:
21890435
3.
4.

Enhanced bioavailability of tamoxifen after oral administration of tamoxifen with quercetin in rats.

Shin SC, Choi JS, Li X.

Int J Pharm. 2006 Apr 26;313(1-2):144-9. Epub 2006 Mar 3.

PMID:
16516418
5.

Effects of silybinin on the pharmacokinetics of tamoxifen and its active metabolite, 4-hydroxytamoxifen in rats.

Kim CS, Choi SJ, Park CY, Li C, Choi JS.

Anticancer Res. 2010 Jan;30(1):79-85.

PMID:
20150620
7.
8.
9.

Enhanced tamoxifen bioavailability after oral administration of tamoxifen in rats pretreated with naringin.

Choi JS, Kang KW.

Arch Pharm Res. 2008 Dec;31(12):1631-6. doi: 10.1007/s12272-001-2161-7. Epub 2008 Dec 20.

PMID:
19099234
10.

Effects of myricetin, an anticancer compound, on the bioavailability and pharmacokinetics of tamoxifen and its main metabolite, 4-hydroxytamoxifen, in rats.

Li C, Lim SC, Kim J, Choi JS.

Eur J Drug Metab Pharmacokinet. 2011 Sep;36(3):175-82. doi: 10.1007/s13318-011-0036-y. Epub 2011 Mar 27.

PMID:
21442417
11.
12.

Effects of quercetin on the bioavailability of doxorubicin in rats: role of CYP3A4 and P-gp inhibition by quercetin.

Choi JS, Piao YJ, Kang KW.

Arch Pharm Res. 2011 Apr;34(4):607-13. doi: 10.1007/s12272-011-0411-x. Epub 2011 May 5.

PMID:
21544726
13.

Enhanced bioavailability of etoposide after oral or intravenous administration of etoposide with kaempferol in rats.

Li C, Li X, Choi JS.

Arch Pharm Res. 2009 Jan;32(1):133-8. doi: 10.1007/s12272-009-1127-z. Epub 2009 Jan 29.

PMID:
19183886
14.
15.
16.

Effects of myricetin on the bioavailability of doxorubicin for oral drug delivery in rats: possible role of CYP3A4 and P-glycoprotein inhibition by myricetin.

Choi SJ, Shin SC, Choi JS.

Arch Pharm Res. 2011 Feb;34(2):309-15. doi: 10.1007/s12272-011-0217-x. Epub 2011 Mar 6.

PMID:
21380815
17.

Effect of genistein on the pharmacokinetics of paclitaxel administered orally or intravenously in rats.

Li X, Choi JS.

Int J Pharm. 2007 Jun 7;337(1-2):188-93. Epub 2007 Jan 7.

PMID:
17267149
18.

Effects of morin on the pharmacokinetics of nicardipine after oral and intravenous administration of nicardipine in rats.

Piao YJ, Choi JS.

J Pharm Pharmacol. 2008 May;60(5):625-9. doi: 10.1211/jpp.60.5.0008.

PMID:
18416939
19.
20.

Effects of oral epigallocatechin gallate on the oral pharmacokinetics of verapamil in rats.

Chung JH, Choi DH, Choi JS.

Biopharm Drug Dispos. 2009 Mar;30(2):90-3. doi: 10.1002/bdd.644.

PMID:
19226653

Supplemental Content

Support Center